Systemic therapy options in malignant bone diseases
Journal Title: Ortopedia Traumatologia Rehabilitacja - Year 2005, Vol 7, Issue 5
Abstract
Bone metastases (secondary bone neoplasms) represent a more significant epidemiological problem than primary bone neoplasms. The differing histogenesis of primary and secondary malignant bone neoplasms (respectively, mesenchymal and epithelial origin) influences the variability of activity and indications for systemic therapy. A common response is the use of systemic therapy within a multidisciplinary therapeutic approach. The principles of chemotherapy used for primary bone neoplasms are essentially similar in spindle-cell and small-cell sarcomas. Initial multi-drug chemotherapy should be administered in all stages. Chemotherapy may also be used following local treatment, although the role of adjuvant chemotherapy is better defined in small-cell sarcomas. Chemotherapy is also applied in the palliative management of disseminated sarcomas.Systemic therapy plays an essential role in the management of patients with bone metastases during the course of breast and prostate carcinoma. The use of hormonal therapy is based on endocrine dependency of both malignancies. Chemotherapy represents a treatment of choice in several clinical situations due to high chemosensitivity of the underlying malignancy (e. g., small-cell lung cancer or lymphoma). Bisphosphonates play an important role in the management of bone metastases. The use of bisphosphonates is most justified in patients with breast cancer, multiple myeloma, and prostate carcinoma.
Authors and Affiliations
Maciej Krzakowski
Keywords
Related Articles
- EP ID EP56376
- DOI -
- Views 88
- Downloads 0
Podskórne wydłużenie ścięgna Achillesa w leczeniu spastycznej w stopy końskiej
Wstęp. Mimo znacznego postępu medycyny jaki dokonał się w ostatnich latach na świecie, liczba dzieci z mózgowym porażeniem systematycznie rośnie, stwarzając często problemy lecznicze. Celem pracy była ocena wydłużania śc...
Dislocation of the patella in a patient with Rubinstein-Taybi syndrome – a case study.
The Rubinstein-Taybi syndrome is a rare syndrome of congenital disorders whose etiology is still unknown. Most RTS patients have musculoskeletal abnormalities which, if untreated, may significantly affect independent mo...
The efficiency assessment of rehabilitation with DBC method in low back pain patients
Rehabilitation in patients with low back pain is one of the crucial therapeutic and social problems. This work attempts to present therapeutic procedures according to DBC (Documentation Based Care) treatment concept.The...
Reconstruction of large bone defects with arthroplasty in the treatment of bone tumors of the hip joint
Background. In a retrospective study of the time of survival, the quality of life and the methods used to reconstruct large bone defects around the hip joint, we examined 13 patients treated surgically in our orthopedic...
Wyniki leczenia dużych ubytków chrząstki stawu kolanowego za pomocą koncentratu komórek szpiku i membrany kolagenowej.
StreszczenieCelem pracy była ocena kliniczna wyników leczenia ubytków chrząstki z pomocą koncentratu komórek szpiku kostnego oraz analiza powikłań. Materiał kliniczny stanowiło 54 chorych z ubytkiem III lub IV stopnia w...